News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
189,715 Results
Type
Article (18192)
Company Profile (126)
Press Release (171389)
Multimedia
Podcasts (46)
Webinars (13)
Section
Business (58540)
Career Advice (951)
Deals (9435)
Drug Delivery (38)
Drug Development (23611)
Employer Resources (73)
FDA (2429)
Job Trends (4298)
News (92819)
Policy (5840)
Tag
Academia (487)
Accelerated approval (7)
Adcomms (16)
Allergies (31)
Alliances (16315)
ALS (56)
Alzheimer's disease (540)
Antibody-drug conjugate (ADC) (129)
Approvals (2391)
Artificial intelligence (171)
Autoimmune disease (44)
Automation (11)
Bankruptcy (83)
Best Places to Work (2892)
BIOSECURE Act (20)
Biosimilars (54)
Biotechnology (115)
Bladder cancer (55)
Brain cancer (21)
Breast cancer (167)
Cancer (1506)
Cardiovascular disease (113)
Career advice (778)
Career pathing (22)
CAR-T (143)
CDC (5)
Cell therapy (388)
Cervical cancer (12)
Clinical research (19696)
Collaboration (685)
Company closure (3)
Compensation (222)
Complete response letters (27)
COVID-19 (771)
CRISPR (38)
C-suite (341)
Cystic fibrosis (53)
Data (1613)
Denatured (6)
Depression (38)
Diabetes (109)
Diagnostics (1124)
Digital health (4)
Diversity (3)
Diversity, equity & inclusion (21)
Drug discovery (102)
Drug pricing (38)
Drug shortages (2)
Duchenne muscular dystrophy (95)
Earnings (16729)
Editorial (20)
Employer branding (8)
Employer resources (71)
Events (32701)
Executive appointments (510)
FDA (3098)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (9)
Funding (596)
Gene editing (86)
Generative AI (17)
Gene therapy (305)
GLP-1 (333)
Government (695)
Grass and pollen (1)
Guidances (77)
Healthcare (2403)
HIV (8)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (138)
Immuno-oncology (17)
Indications (16)
Infectious disease (856)
Inflammatory bowel disease (92)
Inflation Reduction Act (3)
Influenza (36)
Intellectual property (76)
Interviews (141)
IPO (4162)
IRA (14)
Job creations (1480)
Job search strategy (706)
Kidney cancer (7)
Labor market (48)
Layoffs (232)
Leadership (21)
Legal (1204)
Liver cancer (23)
Longevity (5)
Lung cancer (184)
Lymphoma (126)
Machine learning (14)
Management (24)
Manufacturing (290)
MASH (47)
Medical device (693)
Medtech (694)
Mergers & acquisitions (5631)
Metabolic disorders (369)
Multiple sclerosis (57)
NASH (8)
Neurodegenerative disease (106)
Neuropsychiatric disorders (27)
Neuroscience (955)
NextGen: Class of 2025 (1451)
Non-profit (457)
Now hiring (32)
Obesity (191)
Opinion (188)
Ovarian cancer (58)
Pain (49)
Pancreatic cancer (69)
Parkinson's disease (98)
Partnered (13)
Patents (149)
Patient recruitment (123)
Peanut (17)
People (22794)
Pharmaceutical (16)
Phase I (7620)
Phase II (9408)
Phase III (5270)
Pipeline (1027)
Policy (109)
Postmarket research (307)
Preclinical (3144)
Press Release (61)
Prostate cancer (53)
Psychedelics (26)
Radiopharmaceuticals (87)
Rare diseases (301)
Real estate (2456)
Recruiting (38)
Regulatory (4966)
Reports (23)
Research institute (524)
Resumes & cover letters (154)
Rett syndrome (8)
RNA editing (12)
RSV (21)
Schizophrenia (34)
Series A (127)
Series B (85)
Service/supplier (6)
Sickle cell disease (30)
Special edition (14)
Spinal muscular atrophy (51)
Sponsored (14)
Startups (1807)
State (1)
Stomach cancer (6)
Supply chain (31)
Tariffs (35)
The Weekly (40)
Vaccines (305)
Venture capital (57)
Weight loss (126)
Women's health (11)
Worklife (8)
Date
Today (37)
Last 7 days (203)
Last 30 days (939)
Last 365 days (11849)
2025 (9378)
2024 (12648)
2023 (13201)
2022 (16037)
2021 (16924)
2020 (13174)
2019 (9492)
2018 (7536)
2017 (8975)
2016 (8112)
2015 (9408)
2014 (9724)
2013 (9447)
2012 (6079)
2011 (6451)
2010 (5840)
Location
Africa (330)
Alabama (45)
Alaska (3)
Arizona (61)
Arkansas (2)
Asia (13903)
Australia (2751)
California (3474)
Canada (1012)
China (345)
Colorado (60)
Connecticut (135)
Delaware (72)
Europe (31228)
Florida (412)
Georgia (57)
Hawaii (2)
Idaho (13)
Illinois (177)
India (21)
Indiana (173)
Iowa (5)
Japan (122)
Kansas (20)
Kentucky (6)
Louisiana (5)
Maine (2)
Maryland (470)
Massachusetts (2689)
Michigan (101)
Minnesota (162)
Mississippi (1)
Missouri (24)
Montana (9)
Nebraska (4)
Nevada (22)
New Hampshire (7)
New Jersey (827)
New Mexico (11)
New York (849)
North Carolina (522)
North Dakota (6)
Northern California (1566)
Ohio (80)
Oklahoma (10)
Oregon (9)
Pennsylvania (669)
Puerto Rico (5)
Rhode Island (15)
South America (402)
South Carolina (5)
Southern California (1391)
Tennessee (26)
Texas (459)
United States (11665)
Utah (46)
Virginia (30)
Washington D.C. (21)
Washington State (454)
West Virginia (1)
Wisconsin (23)
189,715 Results for "moleculin biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
August 15, 2025
·
3 min read
Press Releases
Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment
August 7, 2025
·
7 min read
Press Releases
Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin
September 26, 2025
·
5 min read
Press Releases
Moleculin Issues New Positive AML Overall Survival Data:
August 28, 2025
·
9 min read
Press Releases
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
August 29, 2025
·
5 min read
Press Releases
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
September 10, 2025
·
8 min read
Press Releases
Moleculin Reports Second Quarter 2025 Financial Results and Highlights
August 14, 2025
·
12 min read
Press Releases
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
September 9, 2025
·
7 min read
Press Releases
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin
July 31, 2025
·
5 min read
Lone Star Bio
Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference
Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company) today announced Walter Klemp, President and Chief Executive Officer of Moleculin will present at the MedInvest Biotech & Pharma Investor Conference behind held in New York City, NY on Thursday, April 4, 2024 at 4:10 PM ET.
March 28, 2024
·
2 min read
1 of 18,972
Next
